Primary Image

Generic Background Image

Clinical Trial

Neuromodulation and Neurorehabilitation for Treatment of Functional Deficits after mTBI plus PTSD

IRB Protocol Number STU00203773

Contact

Katie Kestner ckestner@sralab.org

Objective

The purpose of this study is to alleviate persisting attention deficits related to mild TBI and PTSD by treating the neurocognitive system of attention.

Who Can Participate

  • Mild TBI/concussive event 3 months to 10 years ago
  • Have co-occuring mild TBI and PTSD

Compensation

Provided

Age Range

Age Range 18-80

Apply for this Trial

Your information will not be published.

All fields are required.

Featured Quote

Save now, read later.

More Studies Like This

view all

Latest Updates

view all